Skip to main content
logo
Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
6.79
-0.31 (-4.37%)
At close: Sep 18, 2025, 4:00 PM EDT
6.80
+0.01 (0.15%)
After-hours: Sep 18, 2025, 6:56 PM EDT

Radiopharm Theranostics Cash Flow Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-36.7-47.95-34.61-30.42-1.16
Depreciation & Amortization
2.63.133.32.98-
Loss (Gain) From Sale of Assets
-1.69---
Asset Writedown & Restructuring Costs
-1.483.1--
Stock-Based Compensation
-2.643.044.80.86
Other Operating Activities
-2.548.993.8110.480
Change in Accounts Receivable
-3.48-4.28-0.05-0.02
Change in Accounts Payable
-3.52.352.530.24
Change in Other Net Operating Assets
-0.070.1-0.23-
Operating Cash Flow
-36.65-22.98-23.2-9.91-0.08
Capital Expenditures
---0.05-0-
Sale (Purchase) of Intangibles
3--1.49-28.34-
Investment in Securities
----0.04-
Other Investing Activities
-1.23----
Investing Cash Flow
1.77--1.53-28.38-
Short-Term Debt Issued
---0.01-
Long-Term Debt Issued
-7.37---
Total Debt Issued
-7.37-0.010.14
Short-Term Debt Repaid
-1.9---0.07-
Long-Term Debt Repaid
--5.17---
Total Debt Repaid
-1.9-5.17--0.07-
Net Debt Issued (Repaid)
-1.92.2--0.060.14
Issuance of Common Stock
53.9829.6510.07700
Other Financing Activities
-6.65-1.97-0.85-4.83-
Financing Cash Flow
45.4329.889.2265.110.14
Foreign Exchange Rate Adjustments
-0.01-0.030.230.13-
Net Cash Flow
10.546.88-15.2826.950.07
Free Cash Flow
-36.65-22.98-23.25-9.91-0.08
Free Cash Flow Margin
-273.47%-1173.12%-374.36%--
Free Cash Flow Per Share
-0.02-0.06-0.08-0.06-
Cash Income Tax Paid
--4.85-1.56--
Levered Free Cash Flow
-23.06-12.04-12.08-31.35-
Unlevered Free Cash Flow
-23.02-11.64-12.03-25.51-
Change in Working Capital
-7.05-1.842.250.22
Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q